Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

A 2-year-old boy with a rare type of lupus causing hair loss improved with oral steroids.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Methyl prednisolone helps most patients with alopecia universalis regrow hair.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Betamethasone is more effective long-term for alopecia areata than hydroxychloroquine.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.